¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"basophilic degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic adenoma
    È£¿°±â»ùÁ¾
  • basophilic cell
    È£¿°±â¼¼Æ÷
  • basophilic erythroblast
    È£¿°±âÀûÇ÷¸ð±¸
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • basophilic granule
    È£¿°±â°ú¸³
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸, È£¿°±â°ú¸³±¸
  • basophilic leukocyte
    È£¿°±â¹éÇ÷±¸, È£¿°±â±¸
  • basophilic myelocyte
    È£¿°±â°ñ¼ö¼¼Æ÷
  • basophilic normoblast
    È£¿°±âÀûÇ÷¸ð±¸
  • basophilic promyelocyte
    È£¿°±âÀü°ñ¼ö¼¼Æ÷, È£¿°±âDz»À¼ÓÁú¼¼Æ÷
  • basophilic stippling
    È£¿°±â¹ÝÁ¡
  • angiolithic degeneration
    Ç÷°üµ¹º¯¼º, ¸Æ°ü°á¼®º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic cell
    È£¿°±â¼¼Æ÷
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸
  • degeneration
    º¯¼º, ÅðÇà
  • axonal degeneration
    Ãà»èº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • postencephalitic degeneration
    ³ú¿°Èĺ¯¼º
  • vacuolar degeneration
    °øÆ÷º¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic adenoma
    È£¿°±â»ùÁ¾
  • basophilic cell
    È£¿°±â¼¼Æ÷
  • basophilic erythroblast
    (¢¡basophilic normoblast) È£¿°±âÀûÇ÷¸ð±¸
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • basophilic granule
    È£¿°±â°ú¸³
  • basophilic leukocyte
    È£¿°±â¹éÇ÷±¸
  • basophilic myelocyte
    È£¿°±â°ñ¼ö¼¼Æ÷
  • basophilic normoblast
    È£¿°±âÀûÇ÷¸ð±¸
  • basophilic promyelocyte
    È£¿°±âDz°ñ¼ö¼¼Æ÷
  • basophilic stippling
    È£¿°±â¹ÝÁ¡
  • actinic degeneration
    ±¤¼±º¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • angiolithic degeneration
    ¸Æ°ü°á¼®º¯¼º, Ç÷°üµ¹º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ARMD->age-related macular degeneration
    ¿¬·É°ü·ÃȲ¹Ýº¯¼º,³ë³â±âȲ¹Ýº¯¼º
  • Terriens marginal degeneration
    Å׸®¿£º¯¿¬°¢¸·º¯¼º
  • Wallerian degeneration
    ¿Ð´õº¯¼º
  • actinic degeneration
    ±¤¼±(ÎÃàÊ) º¯¼º(ܨàõ)
  • amyloid degeneration
    ¾Æ¹Ð·ÎÀ̵庯¼º(¡­Ü¨àõ).
  • glycogen degeneration
    ±Û¸®ÄÚ°Õº¯¼º(¡­Ü¨àõ).
  • hepatocereberal degeneration
    °£³úº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º.
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hyaloideoretinal degeneration
    À¯¸®Ã¼¸Á¸·º¯¼º
  • pigmentary degeneration of retina
    ¸Á¸·»ö¼Òº¯¼º(Áõ)(ØÑدßäáÈܨàõ(ñø))
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic degeneration
    È£¿°±â¼º º¯¼º(¡­Ü¨àõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic metaleukocyte juvenile basophilic leukocyte
    È£¿°±â¼º´Ê°ñ¼ö¼¼Æ÷ ¾î¸°È£¿°±â
  • basophilic
    È£¿°±â(¼º)(û¿ç¤Ðñàõ)ÀÇ.
  • basophilic cell
    È£¿°±â(¼º) ¼¼Æ÷(?ËṴ̂).
  • basophilic cell
    È£¿°±â(¼º) ¼¼Æ÷(¡­á¬øà).
  • basophilic cell
    È£¿°±â¼º¼¼Æ÷
  • basophilic erythroblast
    È£¿°±â¼º Àû¾Æ±¸(?ËøËâË´).
  • basophilic erythroblast
    È£¿°±â¼ºÀûÇ÷±¸¸ð¼¼Æ÷
  • basophilic erythrocyte
    È£¿°±â¼º ÀûÇ÷±¸(?ËøÌ´Ë´).
  • basophilic granule
    È£¿°±â¼º°ú¸³
  • basophilic granulocyte
    È£¿°±â¼º °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°¼º(û¿ç¤àõ) °ú¸³±¸(ΨأϹ)
  • basophilic hyperpituitarism
    È£¿°±â¼º ³úÇϼöü±â´ÉÇ×ÁøÁõ.
  • basophilic hypersensitivity
    È£¿°±â±¸ °ú¹Î¹ÝÀÀ
  • basophilic leukemia
    È£¿°±â¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
  • basophilic leukemia
    È£¿°±â±¸¼º ¹éÇ÷º´(¡­ÛÜúìÜ»).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Basophilic metaleukocyte [Juvenile basophilic leukocyte]
    È£¿°±â¼º´Ê°ñ¼ö¼¼Æ÷ [¾î¸°È£¿°±â¼º¹éÇ÷±¸]
    [¿¾ ¿ë¾î] ¿°±âÈ£¼ºÈİñ¼ö¼¼Æ÷
  • Basophilic myelocyte
    È£¿°±â¼º°ñ¼ö¼¼Æ÷
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º°ñ¼ö¼¼Æ÷
  • Basophilic granule
    È£¿°±â¼º°ú¸³
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º°ú¸³
  • Basophilic leukocyte
    È£¿°±â¼º¹éÇ÷±¸
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º¹éÇ÷±¸
  • Basophilic cell
    È£¿°±â¼º¼¼Æ÷
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º¼¼Æ÷
  • Basophilic erythroblast
    È£¿°±â¼ºÀûÇ÷±¸¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ¿°±âÈ£¼ºÀûÇ÷±¸¸ð¼¼Æ÷
  • Basophilic promyelocyte
    È£¿°±â¼ºÇ²°ñ¼ö¼¼Æ÷
    [¿¾ ¿ë¾î] ¿°±âÈ£¼ºÀü°ñ¼ö¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fatty degeneration
    Áö¹æÅðÇà(ò·Û¸÷Üú¼)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÈ­
  • fat degeneration
    Áö¹æº¯¼º
  • fatty degeneration
    Áö¹æº¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • myxomatous degeneration
    Á¡¾×Á¾¼ºº¯¼º
  • retrograde degeneration
    ¿ªÇ༺º¯¼º
  • sclerotic degeneration
    °æÈ­¼ºº¯¼º
  • Wallerian degeneration
    ¿Ð·¯º¯¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BD barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
bas basilar; basophil, basophilic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RBL Rat basophilic leukaemia
RBL-1 Rat basophilic leukaemia
RBL-2H3 Rat basophilic leukaemia cells
RBL-2H3 rat basophilic leukaemia
RBL-1 rat basophilic leukaemia cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • basophilic
    È£¿°±â¼º, È£¿°±âÀÇ, È£¿°±â¼ºÀÇ
    ¿°±â¼º ¿°·á¿¡ ÀÇÇÏ¿© ½±°Ô ¿°»öµÇ´Â.
  • basophilic cell
    È£¿°±â¼º ¼¼Æ÷
  • basophilic erythroblast
    È£¿°±â¼º Àû¾Æ±¸, ¿°±âÈ£¼º ÀûÇ÷±¸ ¸ð¼¼Æ÷
    ¿°±â¼º ¿°·á¿¡ ÀÇÇÏ¿© ½±°Ô ¿°»öµÇ´Â Àû¾Æ±¸. ÀüÀûÇ÷±¸ ¸ð¼¼Æ÷º¸´Ù Å©±â´Â ¾à°£ À۾Ƽ­ Á÷°æÀÌ 10-16§­À̸ç, ÇÙÀº ¾ÆÁ÷µµ Å« ÆíÀ¸·Î ¼¼Æ÷ ÀüüÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϴµ¥, ¿°»öÁúÀº Á» ´õ ³óÃàµÇ¾î ±½Àº ±×¹°±¸Á¶¸¦ º¸À̸ç, ÇÙ ¼Òü´Â Àß ¸ðÀÌÁö ¾Ê´Â´Ù.
  • basophilic leukocyte
    È£¿°±â±¸
    1. ¿°±â¼º ¿°·á¿¡ ÀÇÇÏ¿© ½±°Ô ¿°»öµÇ´Â ¹éÇ÷±¸. Àüü ¹éÇ÷±¸ÀÇ 0.5-1%¸¦ Â÷ÁöÇÑ´Ù. Å©±â´Â »ýü¿¡¼­ 7-9¥ìm Á¤µµÀ̰í Ȱ¹ßÇÑ ¾Æ¸Þ¹Ù¼º À̵¿Àº ¾ø¾î¼­, ´À¸®°Ô À̵¿ÇÑ´Ù. ÇÙÀº ºñ±³Àû Å©°í ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÌ¸ç ºÎºÐÀûÀ¸·Î ¼öÃàµÇ¾î 2°³ÀÇ ¿±À» ÀÌ·ç±âµµ Çϳª ±×´ÙÁö ¶Ñ·ÇÇÏÁö´Â ¾Ê´Ù. ¼¼Æ÷Áú ¼Ó ƯÀÌ °ú¸³µéÀº Å©±â°¡ ´Ù¾çÇϰí histamine, he
  • basophilic stippling
    È£¿°±â¼º ¹ÝÁ¡
    ÀûÇ÷±¸³»¿¡ ¼ö °³¿¡¼­ ½Ê¿©°³ ÃâÇöÇÏ´Â 0.5-1 §­ÀÇ ¼Ò¹ÝÁ¡ÀÌ°í ¿°±â¼º »ö¼Ò·Î °­ÇÏ°Ô ¹°µç´Ù. ³³ Áßµ¶, º¥Á¹ Áßµ¶ µîÀÇ Áßµ¶¼º ºóÇ÷, ¾Ç¼º ºóÇ÷ µî¿¡¼­ º¼ ¼ö ÀÖ°í Æ¯È÷ ±× ȸº¹ ½Ã¿¡ Áõ°¡ÇÑ´Ù.
  • actinic degeneration
    ±¤¼± º¯¼º
  • amyloid degeneration
    ¾Æ¹Ð·ÎÀÌµå º¯¼º
  • axonal degeneration
    Ãà»è º¯¼º
  • ballooning degeneration
    °øÆ÷ º¯¼º, dz¼± º¯¼º, ±â±¸»ó º¯¼º
    Ç¥ÇÇ ¼¼Æ÷³» ºÎÁ¾À¸·Î ÀÎÇÏ¿© ¼¼Æ÷ÀÇ ½ÉÇÑ ÆØÃ¢À» ÀÏÀ¸Å² °Í.
  • calcareous corneal degeneration
    ¼®È¸ °¢¸· º¯¼º
  • calcific degeneration
    ¼®È¸È­ º¯¼º, ÅðÇ༺ ¼®È¸È­
    Ä¡¼ö½Ç º¸´Ù Ä¡¼ö °ü¿¡¼­ ÈçÇÏ´Ù. ¾àÇÑ µ¿Åë. ±¹¼Ò ´ë»ç Àå¾Ö³ª ¼Õ»ó ¼¼Æ÷ÀÇ ÃÊÀÚÈ­ µîÀÌ ¿øÀÎÀÌ´Ù.
  • cancerous degeneration
    ¾Ï º¯¼º
    ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í. ¿¹¸¦ µé¸é ¾ç¼º Á¾¾ç¿¡¼­ ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í.
  • cartilage degeneration
    ¿¬°ñ º¯¼º
    ¿¬°ñÀÌ °íµµÀÇ ÇüÀ¸·ÎºÎÅÍ ÀúµµÀÇ ÇüÀ¸·Î º¯È­.
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º
  • cerebellar degeneration
    ¼Ò³ú º¯¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
basophilic degeneration Blue staining of connective tissues when haematoxylin-eosin stain is used; found in such conditions as solar elastosis.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
basophilic Denoting tissue components having an affinity for basic dyes under specific pH conditions.
Synonym: basophil, basophile.
(05 Mar 2000)
basophilic leukaemia A form of granulocytic leukaemia in which there are unusually great numbers of basophilic granulocytes in the tissues and circulating blood; in some instances, the immature and mature basophilic forms may represent from 40 to 80% of the total numbers of white blood cells.
Synonym: mast cell leukaemia.
(05 Mar 2000)
basophilic leukocyte A polymorphonuclear leukocyte characterised by many large, coarse, metachromatic granules (dark purple or blue-black when treated with Wright's or similar stains) that usually fill the cytoplasm and may almost mask the nucleus; these leukocyte's are unique in that they usually do not occur in increased numbers as the result of acute infectious disease, and their phagocytic qualities are probably not significant; the granules, which contain heparin and histamine, may degranulate in response to hypersensitivity reactions and can be of significance in general inflammation.
Synonym: basocyte, basophilocyte, mast leukocyte.
(05 Mar 2000)
basophilic leukocytosis The presence of an abnormally large number of basophilic granulocytes in the blood.
Synonym: basocytosis.
(05 Mar 2000)
basophilic leukopenia A decrease in the number of basophilic granulocytes normally present in the circulating blood (difficult to evaluate, owing to the small and variable number normally present).
Synonym: basocytopenia, basopenia.
(05 Mar 2000)
basophilic substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
adipose degeneration Abnormal formation of microscopically visible droplets of fat in the cytoplasm of cells, as a result of injury.
Synonym: adipose degeneration, steatosis.
(05 Mar 2000)
adiposogenital degeneration A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
albuminous degeneration An obsolete terms for cloudy swelling.
(05 Mar 2000)
amyloid degeneration Infiltration of amyloid between cells and fibres of tissues and organs.
Synonym: waxy degeneration.
(05 Mar 2000)
angiolithic degeneration Calcareous degeneration of the walls of the blood vessels.
(05 Mar 2000)
ascending degeneration Retrograde degeneration of an injured nerve fibre; i.e., toward the nerve cell of the fibre, degeneration cephalad to a spinal cord lesion.
(05 Mar 2000)
atheromatous degeneration Focal accumulation of lipid material (atheroma) in the intima and subintimal portion of arteries, eventually resulting in fibrous thickening or calcification.
(05 Mar 2000)
axonal degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic
    È£¿°±â¼º ¼¼Æ÷(ƯÈ÷ ¹éÇ÷±¸)ÀÇ
  • degeneration
    Åðº¸;Ÿ¶ô;¾ÇÈ­
  • fatty degeneration
    Áö¹æ º¯Áú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á